tiprankstipranks
Olema Pharmaceuticals (OLMA)
NASDAQ:OLMA
US Market
Holding OLMA?
Track your performance easily

Olema Pharmaceuticals (OLMA) Income Statement

648 Followers

Olema Pharmaceuticals Income Statement

Last quarter (Q3 2024), Olema Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Olema Pharmaceuticals's net income was $-34.55M. See Olema Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
----$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 135.91M$ 104.96M$ 106.99M$ 71.49M$ 21.53M$ 4.32M
Operating Income
$ -135.91M$ -104.96M$ -106.99M$ -71.49M$ -21.53M$ -4.32M
Net Non Operating Interest Income Expense
$ 12.94M$ 8.32M$ 2.23M$ 442.00K$ -593.00K$ 7.00K
Other Income Expense
$ -326.00K$ -19.00K$ -27.00K$ 47.00K--
Pretax Income
$ -122.68M$ -96.66M$ -104.79M$ -71.10M$ -22.12M$ -4.32M
Tax Provision
$ -6.13M$ -6.13M$ -6.68M$ -25.00K--
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -122.68M$ -96.66M$ -104.79M$ -71.10M$ -23.99M$ -4.32M
Basic EPS
$ -2.17$ -2.14$ -2.62$ -1.80$ -3.42$ -0.60
Diluted EPS
$ -2.17$ -2.14$ -2.62$ -1.80$ -3.42$ -0.60
Basic Average Shares
$ 224.06M$ 45.25M$ 40.00M$ 39.52M$ 7.02M$ 7.22M
Diluted Average Shares
$ 224.06M$ 45.25M$ 40.00M$ 39.52M$ 7.02M$ 7.22M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 135.91M$ 104.96M$ 106.99M$ 71.49M$ 21.53M$ 4.32M
Net Income From Continuing And Discontinued Operation
$ -122.68M$ -96.66M$ -104.79M$ -71.10M$ -22.12M$ -4.32M
Normalized Income
$ -127.85M$ -102.79M--$ -22.12M$ -4.32M
Interest Expense
----$ 653.00K$ 0.00
EBIT
$ -126.32M$ -104.96M$ -106.99M$ -71.10M$ -21.47M$ -4.32M
EBITDA
$ -125.09M$ -104.58M$ -106.63M$ -69.43M$ -21.46M$ -4.31M
Currency in USD

Olema Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis